Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures ...

Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...

Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...

Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...

Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...

At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...

One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...

A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...

The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...

Reva Medical, LLC announced the presentation of results from a subgroup analysis of the MOTIV BTK pivotal trial for the ...